What does Cordis do?
Cordis (a Cardinal Health company) develops and manufactures medical devices for diagnostics and interventional procedures to treat patients suffering from coronary and peripheral vascular diseases.
Who owns Cordis Corp?
Cardinal Health
As of October 2015, Cordis is a part of Cardinal Health, bringing together two important players in the healthcare industry and creating an unmatched offering in the cardiovascular space that will ensure greater access to quality products and services worldwide.
Is Cordis J&J?
J&J acquired Cordis for $1.8 billion in 1996. But after acquiring the company, it was unable to keep up the pace of innovation and slipped in the race to create the stent market.
Is Cardinal Health selling Cordis?
Cardinal Health completes sale of Cordis business to Hellman & Friedman. DUBLIN, Ohio, Aug. The sale price of approximately $1 billion includes the buyer’s assumption of certain liabilities and the seller’s retention of certain working capital accounts.
How many employees does Cordis have?
We are Essential to Care™ With more than 50,000 employees worldwide, Cardinal Health helps pharmacies, hospitals, health systems, ambulatory surgery centers, clinical laboratories, and physician offices focus on patient care while reducing costs, enhancing efficiency, and improving quality.
What happened Cordis?
Cardinal Health acquired Cordis from Johnson & Johnson in 2015 for $2 billion. Cardinal Health said it was selling its Cordis cardiovascular business to private equity firm Hellman and Friedman for $1 billion. Johnson & Johnson sold Cordis to Cardinal Health in 2015 for $2 billion.
Who is buying Cordis?
Medical supplies and drugs distributor Cardinal Health on Friday announced it has signed a definitive agreement to sell its Cordis business to private equity firm Hellman & Friedman for approximately $1 billion.
Does Johnson and Johnson own Cordis?
The Cordis Corporation agreed yesterday to be acquired by Johnson & Johnson after its buyout offer was raised to $1.8 billion in stock from $1.6 billion.
Why is Cardinal Health selling Cordis?
Cardinal CEO Mike Kaufmann said in a statement the decision to divest Cordis was based on efforts to focus resources on strategic growth areas “where we are an advantaged owner.”
Can I draw blood from a Cordis?
3.3. If drawing blood with a syringe, connect the syringe to a double connector to facilitate needle-free transfer into blood tubes. the cordis and insert a peripheral venous access device.
Who is Cordis Corporation and what do they do?
Cordis, A Cardinal Health Company A Trusted & Continuing Source of New Products With more than 60 years of developing and delivering pioneering cardiology and endovascular interventional devices, Cordis Corporation has helped physicians treat millions of patients throughout the world.
Where is the Cordis manufacturing plant in Ireland?
In July 2006 Cordis, in conjunction with Johnson & Johnson, decided to make a €100m investment to secure the future of production in Ireland and create a new complement of 460 jobs over a three-year period. “The 180,000ft² plant at Cashel in County Tipperary, which combined functions of manufacturing and development, was built on a 40-acre site.”
When did Cordis become part of Cardinal Health?
As of October 2015, Cordis is a part of Cardinal Health, bringing together two important players in the healthcare industry and creating an unmatched combined offering in the cardiovascular space that will ensure greater access to quality products and services worldwide.
Where does Cordis Corporation make drug eluting stents?
Cordis at Cashel provided the entire production of drug eluting stents for Johnson & Johnson in all markets outside of the US. Alza and Cordis share some common infrastructure and facilities on the site, such as quality control and manufacturing services.